Aprogen Pharmaceuticals Inc (003060) — Capital Reinvestment Ratio
Aprogen Pharmaceuticals Inc (003060) has a Capital Reinvestment Ratio of 0.87x as of December 2022, meaning it reinvests 1% of its operating cash flow (₩676.93 Million) in capital expenditures (₩591.03 Million). See Aprogen Pharmaceuticals Inc (003060) balance sheet quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Aprogen Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2022)
This chart tracks Aprogen Pharmaceuticals Inc's Capital Reinvestment Ratio across 7 annual periods. Check how aggressively does Aprogen Pharmaceuticals Inc reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Aprogen Pharmaceuticals Inc (2010–2022)
Year-by-year Capital Reinvestment Ratio for Aprogen Pharmaceuticals Inc from 2010 to 2022. For live market cap and broader valuation context, see market cap of Aprogen Pharmaceuticals Inc.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.06x | ₩25.73 Billion | ₩1.55 Billion | ▼ -50.2% |
| 2020 | 0.12x | ₩8.09 Billion | ₩976.29 Million | ▼ -96.0% |
| 2019 | 2.98x | ₩713.73 Million | ₩2.13 Billion | ▲ +292.2% |
| 2018 | 0.76x | ₩1.33 Billion | ₩1.01 Billion | ▼ -87.9% |
| 2016 | 6.27x | ₩449.98 Million | ₩2.82 Billion | ▲ +115.6% |
| 2015 | 2.91x | ₩1.85 Billion | ₩5.37 Billion | ▼ -94.1% |
| 2010 | 49.52x | ₩247.92 Million | ₩12.28 Billion | — |